Krystal Biotech Inc.(KRYS)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KRYS Krystal Biotech Inc.

休市中 05-03 16:00:00 EDT

161.10

+0.87

+0.54%

盘后161.10

+0.000.00%

19:58 EDT

最高164.74	最低157.90	成交量45.31万
今开163.55	昨收160.23	日振幅4.27%
总市值45.94亿	流通市值33.36亿	总股本2,851万
成交额7,293万	换手率2.19%	流通股本2,071万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"KRYS","market":"US","secType":"STK","nameCN":"Krystal Biotech Inc.","latestPrice":161.1,"timestamp":1714766400000,"preClose":160.23,"halted":0,"volume":453082,"hourTrading":{"tag":"盘后","latestPrice":161.1,"preClose":161.1,"latestTime":"19:58 EDT","volume":26963,"amount":4343760.3867,"timestamp":1714780734616},"delay":0,"floatShares":20707415,"shares":28514547,"eps":0.39,"marketStatus":"休市中","marketStatusCode":7,"change":0.87,"latestTime":"05-03 16:00:00 EDT","open":163.55,"high":164.74,"low":157.895,"amount":72934829.6418,"amplitude":0.04272,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.39,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714982400000},"adr":0,"listingDate":1505880000000,"adjPreClose":160.23,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":161.1,"preClose":161.1,"latestTime":"19:58 EDT","volume":26963,"amount":4343760.3867,"timestamp":1714780734616},"volumeRatio":1.8503891989651633},"requestUrl":"/m/hq/s/KRYS/wiki","defaultTab":"wiki","newsList":[{"id":"2432418880","title":"Krystal Biotech Inc    预计每股收益 15 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432418880","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432418880?lang=zh_cn&edition=full","pubTime":"2024-05-04 00:09","pubTimestamp":1714752579,"startTime":"0","endTime":"0","summary":"   * Krystal Biotech Inc    将于5月6日公布截至2024年3月31日的财报，预计该公司的季度收入将有所增长。* 根据LSEG的数据，8位分析师的平均预期显示，这家总部位于美国宾夕法尼亚州匹兹堡市的公司预计将实现4742万美元的营收。* LSEG 分析师对 Krystal Biotech Inc 的平均预期为每股收益 15 美分。* 华尔街对 Krystal Biotech Inc 的 12 个月目标价中位数为 197.50 美元，高于其最后收盘价 160.23 美元。5月3日 - 以前季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429311977","title":"HC Wainwright & Co.：重申Krystal Biotech(KRYS.US)评级，由买入调整至买入评级, 目标价200.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2429311977","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429311977?lang=zh_cn&edition=full","pubTime":"2024-04-23 01:55","pubTimestamp":1713808521,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申Krystal Biotech(KRYS.US)评级，由买入调整至买入评级, 目标价200.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404230155238b46fefe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404230155238b46fefe&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419284933","title":"Krystal Biotech, Inc.盘中异动 下午盘快速跳水5.02%报170.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419284933","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419284933?lang=zh_cn&edition=full","pubTime":"2024-03-15 01:31","pubTimestamp":1710437515,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日01时31分，Krystal Biotech, Inc.股票出现异动，股价急速下跌5.02%。截至发稿，该股报170.34美元/股，成交量21.7779万股，换手率0.77%，振幅4.71%。Krystal Biotech, Inc.股票所在的生物技术行业中，整体跌幅为0.80%。Krystal Biotech, Inc.公司简介：Krystal Biotech Inc是美国一家从事医疗保健行业的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240315013155791a850e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240315013155791a850e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418755454","title":"Krystal Biotech, Inc.盘中异动 快速上涨5.01%报178.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2418755454","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418755454?lang=zh_cn&edition=full","pubTime":"2024-03-12 23:44","pubTimestamp":1710258241,"startTime":"0","endTime":"0","summary":"北京时间2024年03月12日23时44分，Krystal Biotech, Inc.股票出现波动，股价急速拉升5.01%。截至发稿，该股报178.93美元/股，成交量12.0082万股，换手率0.42%，振幅6.12%。Krystal Biotech, Inc.股票所在的生物技术行业中，整体涨幅为1.10%。Krystal Biotech, Inc.公司简介：Krystal Biotech Inc是美国一家从事医疗保健行业的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403122344027919c147&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403122344027919c147&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417172927","title":"Krystal Biotech, Inc.盘中异动 临近收盘快速下跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417172927","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417172927?lang=zh_cn&edition=full","pubTime":"2024-03-05 04:54","pubTimestamp":1709585680,"startTime":"0","endTime":"0","summary":"北京时间2024年03月05日04时54分，Krystal Biotech, Inc.股票出现波动，股价急速下跌5.04%。Krystal Biotech, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。其相关个股中，Ocean Biomedical Inc C/Wts 14/02/2028 、Ocean Biomedical, Inc.、Jaguar Health, Inc.涨幅较大，Quoin Pharmaceuticals Ltd、Jaguar Health, Inc.、Ocean Biomedical, Inc.较为活跃，换手率分别为2581.86%、663.17%、232.34%，振幅较大的相关个股有Ocean Biomedical Inc C/Wts 14/02/2028 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Ocean Biomedical, Inc.，振幅分别为232.62%、200.00%、130.00%。Krystal Biotech, Inc.公司简介：Krystal Biotech Inc是美国一家从事医疗保健行业的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403050454417a4961af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403050454417a4961af&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416462391","title":"Krystal Biotech, Inc.2023财年实现净利润10.93百万美元，同比增加107.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416462391","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416462391?lang=zh_cn&edition=full","pubTime":"2024-03-02 00:25","pubTimestamp":1709310307,"startTime":"0","endTime":"0","summary":"12月31日，Krystal Biotech, Inc.公布财报，公告显示公司2023财年净利润为10.93百万美元，同比增加107.81%；其中营业收入为50.70百万美元，每股基本收益为0.40美元。从资产负债表来看，Krystal Biotech, Inc.总负债39.71百万美元，其中短期债务1.47百万美元，资产负债比为0.21，流动比率为0.18。机构评级：截至2023年12月31日，当前有9家机构对Krystal Biotech, Inc.目标价做出预测，其中目标均价为182.33美元，其中最低目标价为168.00美元，最高目标价为208.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403020025168af64889&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403020025168af64889&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416164270","title":"Krystal Biotech, Inc.盘中异动 早盘股价大涨5.13%报167.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416164270","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416164270?lang=zh_cn&edition=full","pubTime":"2024-03-01 23:24","pubTimestamp":1709306657,"startTime":"0","endTime":"0","summary":"北京时间2024年03月01日23时24分，Krystal Biotech, Inc.股票出现异动，股价急速拉升5.13%。截至发稿，该股报167.65美元/股，成交量5.5595万股，换手率0.20%，振幅3.97%。Krystal Biotech, Inc.股票所在的生物技术行业中，整体涨幅为1.86%。其相关个股中，Biovie Inc.、Adial Pharmaceuticals, Inc、Jaguar Health, Inc.涨幅较大，Adial Pharmaceuticals, Inc、Enveric Biosciences, Inc.、Biovie Inc.较为活跃，换手率分别为2981.58%、333.35%、142.08%，振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Jaguar Health, Inc.、Carmell Corp C/Wts 12/07/2028 ，振幅分别为81.48%、72.88%、71.25%。Krystal Biotech, Inc.公司简介：Krystal Biotech Inc是美国一家从事医疗保健行业的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240301232417861da951&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240301232417861da951&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414738998","title":"美国研究综述-Agiliti、Domino's、Krystal 生物技术公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2414738998","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2414738998?lang=zh_cn&edition=full","pubTime":"2024-02-27 19:35","pubTimestamp":1709033708,"startTime":"0","endTime":"0","summary":"    路透社2月27日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Agiliti、多米诺比萨和 Krystal Biotech。公司要闻 * Agiliti Inc   ：杰富瑞将其评级从 \"买入 \"下调至 \"持有  * Autodesk Inc   ：加拿大皇家银行将目标价从280美元上调至290美元  * Domino's Pizza Inc   ：杰富瑞将目标价从400美元上调至455美元  * Itron Inc   ：Canaccord Genuity将目标价从68美元上调至105美元  * Krystal Biotech Inc   ：Evercore ISI将该股从战术跑赢大盘名单中除名  以下是路透社周二报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2414849832","title":"美国研究综述-Agiliti、多米诺比萨、Krystal 生物技术公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2414849832","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2414849832?lang=zh_cn&edition=full","pubTime":"2024-02-27 15:31","pubTimestamp":1709019083,"startTime":"0","endTime":"0","summary":"    路透社2月27日 - 华尔街证券分析师周二调整了对 Agiliti、多米诺比萨和 Krystal Biotech 等几家美国上市公司的评级和目标价。公司要闻             * Agiliti公司  ：杰富瑞将其评级从 \"买入 \"下调至 \"持有  * 多米诺比萨  ：杰富瑞将目标价从400美元上调至455美元              * Krystal Biotech Inc   ：Evercore ISI将其股票从战术跑赢大盘名单中除名  以下是路透社周二报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2414838441","title":"Krystal 生物技术公司公布截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2414838441","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2414838441?lang=zh_cn&edition=full","pubTime":"2024-02-26 22:31","pubTimestamp":1708957890,"startTime":"0","endTime":"0","summary":"   * Krystal Biotech Inc   公布的截至12月底的季度调整后每股收益为30美分，高于去年同期的每股收益1.25美元。九位分析师对该季度的平均预期是每股亏损 38 美分。华尔街预期为每股-95美分至-1美分。* Krystal Biotech Inc公布的本季度每股收益为30美分。* 公司报告的季度净收入为 869 万美元。* 本季度，Krystal Biotech Inc 的股价下跌了 10.3%。* 生物技术和医学研究同行的平均一致建议也是 \"买入\"。华尔街对 Krystal Biotech Inc 的 12 个月目标价中位数为 156.50 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2414804748","title":"Krystal Biotech Inc盘中异动 早盘急速上涨13.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2414804748","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414804748?lang=zh_cn&edition=full","pubTime":"2024-02-26 22:30","pubTimestamp":1708957828,"startTime":"0","endTime":"0","summary":"北京时间2024年02月26日22时30分，Krystal Biotech Inc股票出现异动，股价快速拉升13.87%。Krystal Biotech Inc股票所在的生物技术行业中，整体涨幅为0.66%。其相关个股中，Zyversa Therapeutics Inc、Portage Biotech Inc、Neubase Therapeutics Inc涨幅较大，Zyversa Therapeutics Inc、Lixte Biotechnology Holdings  Inc、Neubase Therapeutics Inc较为活跃，换手率分别为564.90%、56.94%、43.32%，振幅较大的相关个股有Aeon Biopharma Inc、Ibio Inc、Ocean Biomedical Inc，振幅分别为4.30%、4.17%、3.82%。Krystal Biotech Inc公司简介：Krystal Biotech Inc是美国一家从事医疗保健行业的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240226223028861d8623&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240226223028861d8623&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414887110","title":"BUZZ-Krystal 生物技术公司因第四季度业绩乐观而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2414887110","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2414887110?lang=zh_cn&edition=full","pubTime":"2024-02-26 22:07","pubTimestamp":1708956434,"startTime":"0","endTime":"0","summary":"    2月26日 - ** 基因疗法开发商Krystal Biotech   股价盘前上涨13.4%至126.26美元** 公司报告第四季度销售基因疗法Vyjuvek的产品净收入为4214万美元，超过分析师预计的2861万美元 - LSEG数据** 公司第四季度每股亏损 30 美分，低于分析师预计的 39 美分。** 美国 FDA 于 2023 年 5 月批准  KRYS 的 Vyjuvek 用于治疗一种罕见的遗传性皮肤病--萎缩性表皮松解症。** 截至 2023 年 12 月 31 日，公司拥有现金、现金等价物和投资共计 5.941 亿美元。** 股价在过去 12 个月中上涨了 42.3","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2413764208","title":"Krystal Biotech Inc    预计每股亏损 38 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2413764208","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2413764208?lang=zh_cn&edition=full","pubTime":"2024-02-23 22:08","pubTimestamp":1708697290,"startTime":"0","endTime":"0","summary":"   * Krystal Biotech Inc    将于2月26日公布截至2023年12月31日的财报，预计该公司的季度收入将有所增长。* 根据LSEG的数据，9位分析师的平均预期显示，这家总部位于美国宾夕法尼亚州匹兹堡市的公司预计将实现2860.7万美元的营收。* LSEG 分析师对 Krystal Biotech Inc 的平均预期是每股亏损 38 美分。* 华尔街对 Krystal Biotech Inc 的 12 个月目标价中位数为 156.50 美元，高于其上一交易日 111.96 美元的收盘价。2月23日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2411615399","title":"Krystal Biotech Inc盘中异动 下午盘大幅下跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2411615399","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411615399?lang=zh_cn&edition=full","pubTime":"2024-02-14 03:51","pubTimestamp":1707853911,"startTime":"0","endTime":"0","summary":"北京时间2024年02月14日03时51分，Krystal Biotech Inc股票出现波动，股价急速下挫5.21%。Krystal Biotech Inc股票所在的生物技术行业中，整体跌幅为1.31%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Surrozen Inc C/Wts 01/08/2031 、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Biodexa Pharmaceuticals Plc、Revelation Biosciences Inc、Kintara Therapeutics Inc较为活跃，换手率分别为436.27%、235.04%、161.86%，振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 、Tc Biopharm  Plc C/Wts 10/02/2028 、Cingulate Inc C/Wts 10/12/2026 ，振幅分别为186.25%、74.23%、53.85%。Krystal Biotech Inc公司简介：Krystal Biotech Inc是美国一家从事医疗保健行业的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021403515187e6ff50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021403515187e6ff50&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2410908884","title":"再获突破！Krystal Biotech(KRYS.US)Vyjuvek治疗案例登上顶尖医学期刊","url":"https://stock-news.laohu8.com/highlight/detail?id=2410908884","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2410908884?lang=zh_cn&edition=full","pubTime":"2024-02-11 14:16","pubTimestamp":1707632213,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，近日，Krystal Biotech公司宣布，Vyjuvek治疗DEB患者眼科疾病的案例在顶尖医学期刊《新英格兰医学杂志》上发表。这是首个使用这一基因疗法治疗DEB患者眼科并发症的案例，是扩展Vyjuvek使用范围的重要里程碑。据了解，Vyjuvek采用了1型单纯疱疹病毒作为载体。去年Krystal Biotech开发的基因疗法Vyjuvek获得美国FDA的批准上市。Krystal Biotech的研发总裁Suma Krishnan女士表示，很高兴看到基于HSV-1载体的基因疗法在治疗眼科疾病上获得积极的初步数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1071603.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2407655863","title":"Krystal Biotech Inc盘中异动 早盘大幅下跌5.02%报113.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2407655863","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2407655863?lang=zh_cn&edition=full","pubTime":"2024-01-30 23:14","pubTimestamp":1706627695,"startTime":"0","endTime":"0","summary":"北京时间2024年01月30日23时14分，Krystal Biotech Inc股票出现波动，股价大幅跳水5.02%。截至发稿，该股报113.11美元/股，成交量5.8807万股，换手率0.21%，振幅4.05%。Krystal Biotech Inc股票所在的生物技术行业中，整体跌幅为0.80%。其相关个股中，Neximmune Inc、Brainstrom Cell Therapeutics、Kura Oncology Inc涨幅较大，Neximmune Inc、Iterum Therapeutics Plc、Panbela Therapeutics Inc较为活跃，换手率分别为230.03%、153.92%、147.22%，振幅较大的相关个股有Psyence Biomedical Ltd、Neximmune Inc、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为800.00%、58.92%、51.28%。Krystal Biotech Inc公司简介：Krystal Biotech Inc是美国一家从事医疗保健行业的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401302314557a3fb998&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401302314557a3fb998&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2406337743","title":"Krystal Biotech Inc盘中异动 下午盘快速跳水5.10%报114.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2406337743","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2406337743?lang=zh_cn&edition=full","pubTime":"2024-01-27 03:55","pubTimestamp":1706298943,"startTime":"0","endTime":"0","summary":"北京时间2024年01月27日03时55分，Krystal Biotech Inc股票出现异动，股价快速下跌5.10%。截至发稿，该股报114.54美元/股，成交量19.3794万股，换手率0.69%，振幅6.98%。Krystal Biotech Inc股票所在的生物技术行业中，整体涨幅为0.16%。Krystal Biotech Inc公司简介：Krystal Biotech Inc是美国一家从事医疗保健行业的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024012703554387e6909a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024012703554387e6909a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2406405392","title":"Krystal Biotech Inc盘中异动 下午盘快速跳水5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2406405392","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2406405392?lang=zh_cn&edition=full","pubTime":"2024-01-26 02:15","pubTimestamp":1706206512,"startTime":"0","endTime":"0","summary":"北京时间2024年01月26日02时15分，Krystal Biotech Inc股票出现波动，股价快速下跌5.20%。Krystal Biotech Inc股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，Onconetix Inc、Processa Pharmaceuticals Inc、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Processa Pharmaceuticals Inc、Onconetix Inc、Kintara Therapeutics Inc较为活跃，换手率分别为4846.50%、704.47%、156.74%，振幅较大的相关个股有Processa Pharmaceuticals Inc、Onconetix Inc、Neurosense Therapeutics Ltd C/Wts 10/11/2026 ，振幅分别为111.70%、91.69%、70.53%。Krystal Biotech Inc公司简介：Krystal Biotech Inc是美国一家从事医疗保健行业的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024012602151387e68b59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024012602151387e68b59&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2400803144","title":"Krystal Biotech Inc盘中异动 下午盘急速跳水5.15%报118.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2400803144","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2400803144?lang=zh_cn&edition=full","pubTime":"2024-01-04 04:21","pubTimestamp":1704313269,"startTime":"0","endTime":"0","summary":"北京时间2024年01月04日04时21分，Krystal Biotech Inc股票出现波动，股价快速下跌5.15%。截至发稿，该股报118.53美元/股，成交量10.8725万股，换手率0.39%，振幅3.57%。Krystal Biotech Inc股票所在的生物技术行业中，整体涨幅为0.33%。Krystal Biotech Inc公司简介：Krystal Biotech Inc是美国一家从事医疗保健行业的公司。该公司致力于开发和商业化适用于患有皮肤病的患者新疗法的基因治疗公司。该公司计划利用其平台扩展其产品线，在未来包括其他皮肤病适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401040421097a382c36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401040421097a382c36&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2393412086","title":"Krystal Biotech Inc盘中异动 下午盘股价大涨5.01%报122.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2393412086","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2393412086?lang=zh_cn&edition=full","pubTime":"2023-12-23 03:38","pubTimestamp":1703273893,"startTime":"0","endTime":"0","summary":"北京时间2023年12月23日03时38分，Krystal Biotech Inc股票出现异动，股价急速拉升5.01%。截至发稿，该股报122.61美元/股，成交量12.9952万股，换手率0.46%，振幅3.80%。Krystal Biotech Inc股票所在的生物技术行业中，整体涨幅为1.37%。Krystal Biotech Inc公司简介：Krystal Biotech Inc是美国一家从事医疗保健行业的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231223033814861c6836&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231223033814861c6836&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.krystalbio.com","stockEarnings":[{"period":"1week","weight":0.0269},{"period":"1month","weight":-0.0943},{"period":"3month","weight":0.441},{"period":"6month","weight":0.3189},{"period":"1year","weight":0.9603},{"period":"ytd","weight":0.2986}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":-0.0156},{"period":"3month","weight":0.0343},{"period":"6month","weight":0.1762},{"period":"1year","weight":0.262},{"period":"ytd","weight":0.0757}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Krystal Biotech, Inc.于2016年4月开始运营。2017年3月，他们从加利福尼亚州有限责任公司转换为特拉华州C-corporation，并将其名称从Krystal Biotech, LLC更改为Krystal Biotech, Inc。该公司是一家专注于为罕见病患者开发和商业化基因药物的生物技术公司。利用他们基于工程化HSV-1的专利平台，他们创造了载体，可以有效地将治疗性转基因传递给多器官系统中感兴趣的细胞。然后，细胞自身的机制转录并翻译编码的效应物来治疗或预防疾病。他们在医疗保健专业人员的办公室或可能由医疗保健专业人员在患者家中制定无创或微创给药途径的载体。他们的目标是开发易于使用的药物，以显著改善患有罕见疾病和慢性疾病的患者的生活。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.00628},{"month":2,"riseRate":0.714286,"avgChangeRate":0.089681},{"month":3,"riseRate":0.571429,"avgChangeRate":0.056874},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.015567},{"month":5,"riseRate":0.571429,"avgChangeRate":0.052482},{"month":6,"riseRate":0.666667,"avgChangeRate":0.114346},{"month":7,"riseRate":0.666667,"avgChangeRate":0.059963},{"month":8,"riseRate":0.166667,"avgChangeRate":0.002705},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.071903},{"month":10,"riseRate":0.571429,"avgChangeRate":0.058731},{"month":11,"riseRate":0.857143,"avgChangeRate":0.208875},{"month":12,"riseRate":0.571429,"avgChangeRate":-0.00422}],"exchange":"NASDAQ","name":"Krystal Biotech Inc.","nameEN":"Krystal Biotech Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Krystal Biotech Inc.(KRYS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Krystal Biotech Inc.(KRYS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Krystal Biotech Inc.,KRYS,Krystal Biotech Inc.股票,Krystal Biotech Inc.股票老虎,Krystal Biotech Inc.股票老虎国际,Krystal Biotech Inc.行情,Krystal Biotech Inc.股票行情,Krystal Biotech Inc.股价,Krystal Biotech Inc.股市,Krystal Biotech Inc.股票价格,Krystal Biotech Inc.股票交易,Krystal Biotech Inc.股票购买,Krystal Biotech Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Krystal Biotech Inc.(KRYS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Krystal Biotech Inc.(KRYS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况